同位素稀释超高效液相色谱-串联质谱法测定人血清中孕酮

建立了超高效液相色谱-串联质谱(UPLC-MS/MS)测定人血清中孕酮的分析方法。血清样品经乙酸乙酯、正己烷液液萃取(LLE)后,采用Acquity UPLC BEH C₁₈色谱柱(2.1 mm×100 mm,1.7μm)进行梯度分离,色谱运行时间为5 min,采用电喷雾(ESI)正离子电离模式和多反应监测(MRM)扫描模式,同位素内标法定量。考察了两步萃取法对孕酮的提取效果,不同流动相的分离效果以及样品稳定性,结果表明以甲醇-0.1%氨水溶液为流动相时分离效果较好。优化条件下,孕酮在10～10 000pg/mL范围内线性关系良好(r²=0.999 8),方法检出限和定量下限分别为5、10 pg/mL;平均加标回收率为91.5%～106%,日内相对标准偏差(RSD)为1.2%～8.2%,日间RSD为4.1%～9.1%。采用该方法对30个真实血清样品进行测定,孕酮质量浓度为0.050 2～1.363 5 ng/mL,均在正常生理范围内。该方法灵敏度高、准确可靠,可用于临床血清样品中孕酮生理水平的检测。     

液相色谱同位素稀释串联质谱法测定人血清中17β-雌二醇含量

研究建立了以人血清中E2-16,16,17-d3为内标测定17β-雌二醇的液相色谱/串联质谱(ID-LC/MS/MS)方法。血清样品经固相萃取装置(SPE)提取雌二醇,乙酸乙酯萃取净化,吹干复溶后用10-乙基吖啶酮-2-磺酰氯(EASC)进行衍生。以Agilent Eclipse XDB-C18色谱分离柱,乙腈、水梯度洗脱,使用电喷雾三重四极杆串联质谱的多重反应监测模式测定,以校准曲线法进行定量。所建立的液相色谱同位素稀释串联质谱法(ID-LC/MS/MS)对于分析血清17β-雌二醇的批内、批间RSD分别为0.29%～0.73%和0.18%～0.28%,回收率为99.6%～100.2%,采用IFCC RELA比对(JCTLM比对)样品进行了方法比较,测定结果与其他实验室相比偏差在0.8%范围内。方法可作为人血清中17β-雌二醇含量测量参考方法。     

同位素稀释-超高效液相色谱-串联质谱法同时测定精油中的7种雌性激素

建立了采用同位素稀释-超高效液相色谱-串联质谱同时快速测定精油中7种雌性激素(雌三醇、雌二醇、雌酮、炔雌醇、己二烯雌酚、己烷雌酚、己烯雌酚)的方法。样品中雌性激素用乙酸乙酯-正己烷(2:98, v/v)溶液提取后,经硅胶固相萃取小柱净化,通过ACQUITY UPLCTM BEH SHELD RP18色谱柱(100 mm×2.1 mm, 1.7 μm)、以水-乙腈作流动相梯度洗脱对7种雌性激素进行分离,采用串联质谱在负离子扫描方式下通过多反应监测(MRM)模式进行定性定量分析。以雌三醇-D3、雌二醇-D3、己烯雌酚-D6为内标,有效减少了样品基质的影响。该方法对精油中7种雌激素的检出限(LOD)为0.3～7 μg/kg,定量限(LOQ)为1～20 μg/kg。待测物与内标物定量离子的峰面积比值与待测物的质量浓度在20～500 μg/L范围内呈良好的线性关系,相关系数(r2)均大于0.997;在20～500 μg/kg范围内3个水平的加标平均回收率为88.5%～114.8%,日内精密度(以相对标准偏差计)(n=6)为4.8%～18.9%。应用该方法对浙江杭州地区不同超市或美容院随机采集的12份精油样品进行测定的结果显示,有1份样品含有雌二醇和雌酮,其余11份样品均未检出雌性激素。     

液相色谱-串联质谱法同时测定人血清中皮质酮与皮质醇

建立了同时测定人血清中皮质酮和皮质醇的液相色谱-串联质谱法。血清经正己烷除脂净化、叔丁基甲醚提取后,以乙腈-0.1%甲酸溶液(含0.01 mol/L甲酸铵)为流动相,流速为0.3 mL/min。用Agilent E-clipse Plus-C18色谱柱(150 mm×2.1 mm,3.5μm)分离,正离子模式下进行串联质谱检测。皮质酮和皮质醇浓度在0.5～200 ng/mL范围内线性关系良好,相关系数(r2)分别为0.999 7、0.999 4。皮质酮和皮质醇分别在5.0、25.0、75.0 ng/mL和0.5、2.5、10.0 ng/mL 3个加标水平下的平均回收率为86.6%～102.7%,相对标准偏差不大于7.1%,检出限分别为0.1 ng/mL和0.05 ng/mL。该方法操作简便、灵敏度高、重现性好、定性定量准确,适用于同时测定血清中的内皮质酮和皮质醇。     

同位素稀释高效液相色谱-串联质谱法测定水体、底泥、鱼及虾中氯硝柳胺残留量

建立了水体、底泥、鱼体自然比例带皮肌肉和虾肌肉中氯硝柳胺(NIC)残留量测定的同位素稀释高效液相色谱-串联质谱(HPLC-MS/MS)法。水样经碱化后以乙酸乙酯提取,其他样品采用0.1%氨水乙腈提取,C₁₈粉进行样品净化。以乙腈-水为流动相,流速为0.3 mL/min,采用Thermo Hypersil Gold C₁₈(150 mm×2.1 mm,5μm)色谱柱进行分离,氯硝柳胺稳定同位素标记物(氯硝柳胺-¹³C₆)为内标,选择反应监测(SRM)模式扫描,内标法定量。结果表明氯硝柳胺在0.2～200μg/L范围内呈良好线性关系,相关系数(r²)不小于0.999 5。空白水样在2.5、25、250 ng/L加标水平下的平均回收率为90.5%～109%,相对标准偏差(RSD)为3.2%～11%,检出限(LOD)为1.0 ng/L,定量下限(LOQ)为2.5 ng/L;空白底泥、黄颡鱼自然比例带皮肌肉和克氏原螯虾肌肉在0.5、5.0、50μg/kg加标水平下的平均回收率分别为89....     

同位素稀释高效液相色谱串联质谱法测定猪肝中地塞米松和倍他米松残留量

建立了同位素稀释高效液相色谱串联质谱法测定猪肝中地塞米松和倍他米松残留量的分析方法。样品经酶解后用乙腈提取,再经C18固相萃取和碳酸钠溶液液液萃取净化,净化后的样品经氮气吹干后用流动相溶解。采用Hypercarb C18柱,以乙腈-水-甲酸(95∶5∶0.5,V/V)混合溶液为流动相,进行高效液相色谱串联质谱分析,同位素内标法定量分析。地塞米松和倍他米松的检出限为别为0.12和0.14μg/kg,定量限分别为0.42和0.47μg/kg。在添加浓度0.75～2.0μg/kg范围内,平均添加回收率为97.3%～111%,批内和批间相对标准偏差(RSD)分别为1.85%～5.65%和2.78%～7.98%。待测物定量离子对峰面积与内标物峰面积比值与标样浓度在10～500μg/L范围内呈良好的线性关系,线性回归系数大于0.9997。     

同位素稀释-超高效液相色谱-串联质谱法测定中药材中的17种真菌毒素

称取2.000g试样于50 mL离心管中,加入乙腈-水-甲酸(70+29+1)混合溶液20.0mL,浸泡60min,于振荡混匀器上提取30min,超声提取30min,离心后,取上清液2.0mL,加入同位素内标混合溶液50μL,用磷酸盐缓冲溶液稀释至20.0mL得样品溶液。样品溶液以1～3mL·min~(-1)流量通过免疫亲和柱,用5mL水淋洗免疫亲和柱,弃去全部流出液,再用2mL甲醇-乙酸(98+2)溶液洗脱免疫亲和柱2次,收集全部洗脱液于试管中,于50℃下氮吹至近干,加入乙腈(1+9)溶液0.5mL溶解残渣,离心后,上清液供超高效液相色谱-串联质谱法分析。为了校正样品净化过程和离子化过程的损失以及消除基质效应,选用稳定性同位素[13 C]为内标物。17种真菌毒素的质量浓度在一定范围内与其峰面积与内标的峰面积的比值呈线性关系,检出限(3S/N)在0.1～2.0μg·L~(-1)之间。对空白中药材样品进行加标回收试验,回收率在84.3%～104%之间,测定值的相对标准偏差(n=6)在1.9%～13%之间。     

稳定同位素稀释超高效液相色谱-串联质谱法测定饲料中氟虫腈及其代谢物

建立了超高效液相色谱-串联质谱测定饲料中氟虫腈及其代谢物氟甲腈、氟虫腈硫醚和氟虫腈砜的方法。样品经纯水和乙腈超声提取后加入氯化钠盐析,采用QuEChERS技术净化,以Waters HSS T3 C₁₈色谱柱分离,甲醇和纯水为流动相进行梯度洗脱,在多反应监测、负离子模式下进行检测,内标法定量。氟虫腈及其代谢物在各自的范围内呈良好的线性关系,相关系数均大于0.9998;氟虫腈及其代谢物的检出限和定量限分别为0.05 μg/kg和0.2 μg/kg,加标回收率为92.3%~105.4%,相对标准偏差为0.9%~2.3%（n=5）。该法样品前处理过程简单,净化效果好,灵敏度高,适用于各种饲料中氟虫腈及其代谢物含量的测定。     

稳定同位素直接稀释/超高效液相色谱-串联质谱法测定葡萄酒中赭曲霉毒素A

建立了稳定同位素直接稀释/超高效液相色谱-串联质谱(UPLC-MS/MS)测定葡萄酒中赭曲霉毒素A(OTA)的方法。葡萄酒样品经乙腈-水-甲酸(29.8∶70∶0.2,体积比)溶液稀释后,加入稳定同位素消除基质效应的影响。采用ACQUITY BEH C_(18)色谱柱(100 mm×2.1 mm,1.7μm)分离,以0.1%甲酸水-0.1%甲酸乙腈为流动相梯度洗脱,以电喷雾离子源正离子模式(ESI~+)扫描,多反应监测(MRM)模式采集,内标法定量。结果表明,OTA在0.05～1μg/L范围内线性关系良好,相关系数(r~2)为0.999 6,检出限(LOD,S/N≥3)为0.1μg/L,定量下限(LOQ,S/N≥10)为0.3μg/L。在1.00、2.00、5.00μg/L加标水平下,回收率为102%～113%,日内相对标准偏差(RSD)为4.1%～9.4%,日间RSD为4.4%～9.7%。利用该方法对国产品牌的15种红葡萄酒和5种白葡萄酒进行测定,均未检出OTA。此方法简单、高效、节约成本,可用于大批量葡萄酒中OTA的快速、准确检测。     

同位素稀释-超高效液相色谱-串联质谱法测定化妆品中香兰素和乙基香兰素

建立同位素稀释-超高效液相色谱-串联质谱法同时测定化妆品中两种香兰素类香料的方法。取1 g样品，加入50μL质量浓度均为1 mg/L的香兰素-D3、乙基香兰素-D5混合同位素内标溶液，以甲醇为提取溶剂，溶解后定容至10 mL，在室温下超声提取15 min，离心分离后，取1 mL上清液用氮气吹干，再用1 mL 0.1%甲酸水溶液-甲醇(体积比为80∶20)定容，过滤后上机分析。经RRHD Eclipse Plus C₁₈色谱柱分离后，使用ESI源对目标物进行电离，在多反应监测模式下绘制色谱图，内标法定量。在5～100μg/L范围内，香兰素、乙基香兰素与内标的质量浓度比与对应色谱峰面积的比线性关系良好，相关系数均大于0.999，方法检出限均为5μg/kg。空白样品加标回收率分别为87.8%～96.1%、80.1%～83.8%，测定结果的相对标准偏差分别为2.5%～3.8%、1.7%～4.6%(n=6)。该方法操作简便，可满足同时测定化妆品中两种香兰素类香料的要求。     

Analysis of aflatoxin B1-lysine adduct in serum using isotope-dilution liquid chromatography/tandem mass spectrometry

A method for quantitative analysis of aflatoxin B1-lysine adduct (B1-Lys) in serum by liquid chromatography using tandem mass spectrometry (LC/MS/MS) is presented. The protein in a 250-microL sample was digested in the presence of a stable-isotope internal standard during a 4-h incubation at 37 degrees C with Pronasetrade mark. B1-Lys and the internal standard were extracted using mixed-mode solid-phase extraction cartridges and eluted with 2% formic acid in methanol. Following evaporation and reconstitution, extracts were injected onto a Luna C-18(2) column and eluted with a step gradient of acetonitrile and 0.06% formic acid. The B1-Lys and the internal standard were detected in a positive ionization selective reaction monitoring mode with a ThermoFinnigan TSQ Quantum triple quadrupole mass spectrometer. Calibration curves were linear for concentrations from 0.05-8.0 ng/mL. The method was validated with aflatoxin B1 dosed rat serum diluted to anticipated high and low concentrations. Total imprecision determined from 30 measurements over 15 days was 5.6% and 9.1%, respectively. Recoveries of 78.8 +/- 6.4% for B1-Lys and 85.4 +/- 12.4% for the internal standard were based on the full extraction and reconstitution processes. The method can be used to quantitate B1-Lys at the 0.5 pg/mg albumin level and is suitable for routine analysis.     

Determination of phenylalanine in human serum by isotope dilution liquid chromatography/tandem mass spectrometry

Isotope dilution liquid chromatography/tandem mass spectrometry (ID-LC/MS/MS) has been developed as a candidate reference method to determine the level of phenylalanine in human serum. The advantages of this method include a simple sample preparation without derivatization, selective detection of analytes, and the use of an isotopic analogue as an internal standard. Phenylalanine and its isotopic analogue, phenylalanine-ring-(13)C(6), were monitored at the transitions m/z 166.2/120.2 and 172.2/126.2 in the multiple-reaction monitoring (MRM) mode, respectively. The expanded uncertainty of the measurement result of phenylalanine in the serum was approximately 1.2% within a 95% confidence level. A standard reference material, with a certified value of phenylalanine, was analyzed in order to verify this method. The result obtained by the ID-LC/MS/MS method differed somewhat from the certified value, but agreed well with the gravimetric value. The measurement result of phenylalanine in serum by ID-LC/MS/MS was compared with the results from the commercial HPLC method, which was carried out in clinics. The results from the commercial HPLC method showed inconsistent results with each other. The busted results from the commercial HPLC method suggest that it should be possible to trace the results of the commercial fields to well-characterized reference materials or methods.     

Determination of 2-methoxyestradiol in human plasma, using liquid chromatography/tandem mass spectrometry

A liquid chromatography/tandem mass spectrometric (LC/MS/MS) assay was developed for the quantitative determination of 2-methoxyestradiol (2ME2) in human plasma. Sample pretreatment involved liquid-liquid extraction with ethyl acetate of 0.3-mL aliquots of plasma spiked with the internal standard, deuterated 2ME2 (2ME2-d5). Separation was achieved on a Zorbax Eclipse C18 column (2.1 x 50 mm, i.d., 5 microm) at room temperature using a gradient elution with methanol and water at a flow rate of 0.25 mL/min. Detection was performed using atmospheric pressure chemical ionization MS/MS by monitoring the ion transitions from m/z 303.1 --> 136.8 (2ME2) and m/z 308.1 --> 138.8 (2ME2-d5). Calibration curves were linear in the concentration range of 1-100 ng/mL. The accuracy and precision values, obtained from three different sets of quality control samples analyzed in quintuplicate on four separate occasions, ranged from 105-108% and from 3.62-5.68%, respectively. This assay was subsequently used for the determination of 2ME2 concentration in plasma of a patient with cancer after a single oral administration of 2ME2 at a dose of 2200 mg.     

Determination of iodoacetic acid using liquid chromatography/electrospray tandem mass spectrometry

A rapid analytical method based on liquid chromatography/tandem mass spectrometry (LC/MS/MS) using electrospray ionization in negative ion detection mode was developed for the analysis of underivatized iodoacetic acid in water. The method was applied to model reaction mixtures in the study of the formation of iodoacetic acid after chlorinated tap water was boiled in the presence of potassium iodide or iodized table salt. Samples can be directly analyzed by the LC/MS/MS system without extraction or chemical derivatization. Limit of detection was determined to be 0.3 microg/L (or 0.3 ng/mL) and limit of quantitation was about 1 microg/L (1 ng/mL).     

Determination of miglitol in human plasma by liquid chromatography/tandem mass spectrometry

A rapid and sensitive method for the determination of miglitol in human plasma using voglibose as internal standard has been developed and validated. Samples of plasma were deproteinated with acetonitrile and washed with dichloromethane before being analyzed by reversed-phase high-performance liquid chromatography (HPLC). Separation was carried out on a short Nucleosil C(18) column (5 microm, 50 x 4.6 mm i.d.) using 10 mmol/L ammonium acetate at 1.0 mL/min as mobile phase. The detector was an Applied Biosystems Sciex API 4000 mass spectrometer using atmospheric pressure chemical ionization (APCI) for ion production. The instrument was operated at unit resolution in the multiple reaction monitoring mode. The assay was linear over the range 5.00-2000 ng/mL with a limit of detection of 1.00 ng/mL. Intra- and inter-day precision were <2.82% and <2.92%, respectively, with accuracy of 93.3-106%. The assay was successfully applied to a clinical pharmacokinetic study of miglitol given as a single oral dose (50 mg) to healthy volunteers.     

Determination of Synacthen in human plasma using immunoaffinity purification and liquid chromatography/tandem mass spectrometry

Synacthen is a synthetic analogue to human adrenocorticotropin, which plays an important physiological role by stimulating production of cortisol. In sports, corticosteroids as well as releasing factors (corticotropins) are prohibited according to the regulations of the World Anti-Doping Agency, and the misuse of Synacthen has been reported several times. Hence, an assay enabling the detection of Synacthen in doping control samples has been developed using immunoaffinity chromatographic isolation of Synacthen from human plasma combined with a concentration of collected fractions using solid-phase extraction. Unambiguous determination of the target analyte was accomplished using microbore liquid chromatography/electrospray ionization tandem mass spectrometry. Diagnostic product ions such as m/z 223 were characterized using high-resolution/high-accuracy Orbitrap mass spectrometry and employed for triple quadrupole MS/MS analysis. The established assay requiring 2 mL of plasma allowed a lower limit of detection (LLOD) at 100 fmol/mL, a recovery of 97% and a precision at the LLOD < 20%. Authentic plasma samples obtained from a patient undergoing a standard short Synacthen test were used to prove the applicability of the developed procedure.     

Determination of lamivudine/stavudine/efavirenz in human serum using liquid chromatography/electrospray tandem mass spectrometry with ionization polarity switch

A high-performance liquid chromatography/tandem mass spectrometry (LC-MS-MS) method with ionization polarity switch was developed and validated in human serum for the determination of a lamivudine (3TC)/stavudine (d4T)/efavirenz combination HIV therapy. Solid phase extraction (SPE) was used to extract these anti-HIV drugs and internal standard aprobarbital. A gradient mobile phase consisting of acetonitrile and 20 mM ammonium acetate buffer with pH adjusted to 4.5 using glacial acetic acid was utilized to separate these drugs on a hexylsilane column (150 x 2.0 mm i.d.). The total run time between injections was 18 min. The precursor and major product ions of these drugs were monitored on a triple quadrupole mass spectrometer in the multiple reactions monitoring (MRM) mode. Ionization polarity was switched in the middle of the LC run allowing these anti-HIV drugs with different physicochemical properties to be detected simultaneously. The effect of ion suppression from human serum was studied and no interference with the analysis was noted. The method was validated over the range of 1.1-540 ng/mL for 3TC, 12.5-6228 ng/mL for d4T and 1.0-519 ng/mL for efavirenz. The method was shown to be accurate, with intra-day and inter-day accuracy less than 14.0% and precise, with intra-day and inter-day precision less than 13.1%. The extraction recoveries of all analytes were higher than 90%.     

Determination of gatifloxacin in human plasma by liquid chromatography/electrospray tandem mass spectrometry

Gatifloxacin is an advanced-generation, 8-methoxyfluoroquinolone that is active against a broad spectrum of pathogens, including antiobiotic resistant Streptococcus pneumoniae. Development of a rapid, sensitive and selective method for the determination of gatifloxacin in human plasma is essential for understanding the pharmacokinetics of the drug when administered orally or intravenously. Solid phase extraction (SPE) using Oasis HLB was used to extract gatifloxacin and the internal standard ciprofloxacin from plasma. A method based on liquid chromatography/electrospray tandem mass spectrometry (LC/ESI-MS/MS) was developed and validated to quantitate gatifloxacin in human plasma. The precursor and major product ions of the analyte were monitored on a triple quadrupole mass spectrometer with positive ion electrospray ionization (ESI) in the multiple reaction monitoring (MRM) mode. Mechanisms for the formation of collision-induced dissociation products of gatifloxacin are proposed. Linear calibration curves were generated from 10--1000 ng/mL with coefficients of determination greater than 0.99. The interday and intraday precision (%RSD) was less than 6.0% and accuracy (%error) was less than 5.4% for gatifloxacin. The limit of detection (LOD) for the method was 500 pg/mL based on a signal-to-noise ratio of 3.     

Determination of azaspiracids in shellfish using liquid chromatography/tandem electrospray mass spectrometry.

Azaspiracid (AZA1), a recently discovered marine toxin, is responsible for the new human toxic syndrome, azaspiracid poisoning (AZP), which is caused by the consumption of contaminated shellfish. A new, sensitive liquid chromatography/mass spectrometry (LC/MS) method has been developed for the determination of AZA1 and its analogues, 8-methylazaspiracid (AZA2) and 22-demethylazaspiracid (AZA3). Separation of these toxins was achieved using reversed-phase LC and coupled, via an electrospray ionisation (ESI) source, to an ion-trap mass spectrometer. Spectra showed the protonated molecules, [M + H]+, and their major product ions, due to the sequential loss of two water molecules, [M + H - H2O]+, [M + H - 2H2O]+, in addition to fragment ions that are characteristic of these cyclic polyethers. A highly specific and sensitive LC/MS(3) analytical method was developed and, using shellfish extracts containing AZA1, the detection limit (S/N = 3) was 4 pg on-column, corresponding to 0.8 ng/mL. Using the protocol presented here, this is equivalent to 0.37 ng/g shellfish tissue and good linear calibrations were obtained for AZA1 in shellfish extracts (average r2 = 0.9988). Good reproducibility was achieved with % RSD values (N = 5) ranging from 1.5% (0.75 microg/mL) to 4.2% (0.05 microg/mL). An efficient procedure for the extraction of toxins from shellfish aided the development of a rapid protocol for the determination of the three predominant azaspiracids.